Mercado de kits de testes domésticos da América do Norte – Tendências do setor e previsão para 2029

Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista  Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado de kits de testes domésticos da América do Norte – Tendências do setor e previsão para 2029

  • Healthcare
  • Publish Reports
  • Aug 2022
  • North America
  • 350 Páginas
  • Número de tabelas: 82
  • Número de figuras: 44

>Mercado de kits de testes em casa da América do Norte, por tipo de teste (teste de gravidez, kit de teste de VIH , diabetes, doenças infecciosas, testes de glicose, kit de teste preditor de ovulação, kit de teste de abuso de drogas e outros), tipo (cassete, tira, midstream, Painel de Teste, Cartão Dip e Outros), Idade (Pediátrica, Adulto e Geriátrica), Tipo de Amostra (Urina, Sangue, Saliva e Outros Tipos de Amostra), Utilização (Descartável e Reutilizável), Canais de Distribuição (Farmácias de Retalho, Drogarias, Supermercado/ Hipermercados e Farmácias Online) - Tendências e previsões do setor para 2029.

Mercado de kits de teste doméstico

Análise e insights de mercado de kits de teste doméstico na América do Norte

Espera-se que o mercado de kits de testes caseiros na América do Norte cresça, uma vez que antes as pessoas costumavam visitar hospitais com frequência, mesmo para problemas básicos, mas devido à crescente consciencialização em relação a diversos produtos, este comportamento mudou e alterou a tendência . Os kits caseiros ou de autoteste estão facilmente disponíveis nas farmácias e tornou-se extremamente fácil adquiri-los. Várias empresas médicas estão a aventurar-se neste espaço à medida que fabricam rapidamente kits de autoteste.

Mercado de kits de teste doméstico

Mercado de kits de teste doméstico

Esta ampla disponibilidade também pode ser atribuída às startups médicas de farmácias online, facilitando a disponibilidade clicando num botão. Além disso, estes kits de autoteste estão disponíveis sem qualquer receita médica, o que pode facilmente impulsionar o mercado dos kits de teste caseiros. Os kits de teste caseiros permitem que os utilizadores finais recolham as suas amostras em casa e, em seguida, realizem os testes em casa ou enviem a amostra para o laboratório para teste. Os kits de teste caseiro facilitaram, sem dúvida, o processo de confirmação da preocupação da pessoa, seja um teste de gravidez caseiro ou de VIH, ou qualquer outro teste de doenças infecciosas.

Estes kits de teste caseiros são fáceis de utilizar e também acessíveis. No entanto, existem sempre dúvidas sobre a precisão dos resultados, o que se tornou uma restrição para o mercado de kits de teste caseiros na América do Norte. Um resultado falso positivo de um teste pode causar ansiedade e stress à pessoa, mesmo que não o tenha. É muito perturbador e perturbador para a pessoa receber resultados falsos positivos ou negativos. Hoje em dia, muitas empresas produzem kits de testes de diagnóstico rápido para COVID-19, que podem ser realizados em casa. Mas existem vários problemas relacionados com a precisão devido aos quais a distribuição destes kits de teste caseiros que foram suspensos da verificação da sua fiabilidade.

A Data Bridge Market Research analisa que o mercado norte-americano de kits de teste caseiros crescerá a um CAGR de 6,3% durante o período de previsão de 2022 a 2029.

Métrica de reporte

Detalhes

Período de previsão

2022 a 2029

Ano base

2021

Anos históricos

2020 (personalizável para 2019-2014)

Unidades Quantitativas

Receita em milhões de dólares, preços em dólares

Segmentos cobertos

By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card and Others), Age (Pediatric, Adult and Geriatric), Sample Type (Urine, Blood, Saliva and Other Sample Types), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket and Online Pharmacies)

Countries Covered

U.S., Canada and Mexico

Market Players Covered

Abbott, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, BD, Drägerwerk AG & Co. KGaA, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG., Nectar Lifesciences Ltd. (Rapikit), ACON Laboratories, Inc., Quidel Corporation., ARKRAY USA, Inc., BTNX INC., Atomo Diagnostics, Eurofins Scientific, Piramal Enterprises Ltd., Bionime Corporation., Nova Biomedical, Cardinal Health., OraSure Technologies, Biolytical Laboratories Inc., Everlywell, Inc., SA Scientific Ltd., Clearblue (a subsidiary of Swiss Precision Diagnostics GmbH), Biosynex, PRIMA Lab SA, MP BIOMEDICALS., Sterilab Services, Chembio Diagnostics, Inc., BioSure, Selfdiagnostics OU among others

North America At-Home Testing Kits Market Definition

At-home testing kits means testing instruments which help people to perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of the diabetic patient. At-home tests are very convenient to perform with comfort at home and are available at very affordable rate. Self-tests are usually the advance versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and can be performed by common person. Their processes, packaging and instructions have been simplified so as to guide person through the steps of taking a test. Various at-home test kits are available including HIV tests, pregnancy test, diabetes, ovulation test, infectious diseases such as malaria, COVID-19 and others.  For performing these rapid at-home tests blood, urine and oral fluid can be taken as a sample.

North America At-Home Testing Kits Market Dynamics

Drivers

  • Growing adoption of self-testing kits                          

Earlier, people used to visit hospitals often, even for basic problems. However, as awareness has grown regarding several products, this behavior has changed and has turned the trend. Nowadays, people prefer to get their basic tests done using test kits at home before visiting a doctor.

This has become even more prominent due to this pandemic as people are adopting more self-help testing kits due to several restrictions in place. It has turned out to be a boon in disguise for both hospitals and patients as hospitals are already stretched thin and can entirely focus on COVID-19 patients, and the patients can save hefty costs of doctor visits and medicine fees. It has become highly convenient for consumers as they can quickly know their tests' results at their fingertips.

  • Easy availability of self-testing kits at pharmacies

At-home or self-testing kits are easily available at pharmacies, and it has become effortless to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits.

This widespread availability can also be attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, these self-testing kits are available without any prescription.

Opportunity

  • Advent of advanced technologies

The latest technologies are crucial in making medical products very advanced and reliable to trust. In different medical devices, Artificial Intelligence (AI) and Machine Learning (ML) are important aspects of the healthcare sector with the ability to enhance patient safety and administrative processes by work automation and quicker performance.

It is certain that, by default, AI-powered diagnostic instruments will continue to develop. AI has only taken modest moves into a huge and multi-dimensional opportunity in the healthcare sector.

Restraint/Challenge

  • Inaccuracy of results by self-testing kits

At-home testing kits allow end-users to collect their specimen at home and perform the tests at home or send that specimen to the lab for testing. At-home testing kits have undoubtedly eased the process of confirming the person's concern, whether it is a home pregnancy test, HIV test, or any other infectious diseases test.

These at-home testing kits are easy to use and are affordable too. However, there is always a doubt about the accuracy of the results. COVID-19 home monitoring can be more comfortable than going to a hospital or doctor's office. It will also help reduce the risk of the coronavirus being spread or acquired when you are screened.

However, a false positive test result may cause anxiety and stress to the person, even if they do not have it. It is very upsetting and disturbing to the person to receive false positive or negative results. Today, many companies produce rapid diagnostic test kits for COVID-19 which can be performed at home, but there are various accuracy-related issues due to which the distribution of those at-home test kits has been suspended from verifying their reliability.

Post COVID-19 Impact on North America At-Home Testing Kits Market

O COVID-19 criou um grande impacto no mercado de kits de teste doméstico. O mercado dos kits de teste caseiros está a expandir-se como consequência do aumento da popularidade dos kits de autoajuda e do tipo faça você mesmo (faça você mesmo), devido à sua conveniência e resultados rápidos. Os consumidores estão preocupados com a fiabilidade dos kits de teste rápido em casa, o que poderá impedir a expansão do mercado de kits de teste em casa. Os kits de teste rápido para COVID-19 são agora urgentemente necessários para as empresas, a fim de reduzir a mortalidade dos doentes e aumentar as taxas de recuperação dos doentes e também aumentar a taxa para o mercado de kits de teste domiciliários para doentes diabéticos e doentes com problemas cardíacos. Isto está a criar uma grande oportunidade de mercado para os kits de teste caseiros.

Desenvolvimento recente

  • Em março de 2022, a LifeScan IP Holdings, LLC anunciou que o produto da empresa, OneTouch Verio Flex, liderava os melhores medidores de glicose padrão da Forbes Health com base no preço, tiras de teste acessíveis, indicador de gama de cores, pequena amostra de sangue e design compacto. Isto ajudou a empresa a aumentar a sua presença global no mercado

Âmbito do mercado de kits de testes domésticos da América do Norte

O mercado norte-americano de kits de teste caseiros está categorizado em seis segmentos notáveis ​​com base no tipo de teste, tipo, idade, tipo de amostra, utilização e canais de distribuição. O crescimento entre estes segmentos irá ajudá-lo a analisar os segmentos de crescimento do mercado nas indústrias e fornecer aos utilizadores uma valiosa visão geral do mercado e insights de mercado para os ajudar a tomar decisões estratégicas para identificar as principais aplicações do mercado.

Tipo de teste

  • Teste de gravidez
  • Kit de teste VIH
  • Diabetes
  • Doenças Infecciosas
  • Testes de glicose
  • Kit de teste preditor da ovulação
  • Kit de teste de abuso de drogas
  • Outros

Com base no tipo de teste, o mercado de kits de teste doméstico da América do Norte está segmentado em teste de gravidez, kit de teste de VIH, diabetes, doenças infecciosas, testes de glicose, kit de teste preditor de ovulação, kit de teste de abuso de drogas, entre outros.

Tipo

  • Cassete
  • Faixa
  • Meio caminho
  • Painel de teste
  • Cartão de mergulho
  • Outros

Com base no tipo, o mercado norte-americano de kits de teste doméstico está segmentado em cassete, tira, midstream, painel de teste, cartão dip, entre outros.

Idade

  • Pediátrico
  • Adulto
  • Geriátrico

Com base na idade, o mercado norte-americano de kits de teste caseiros está segmentado em pediátrico, adulto e geriátrico.

Tipo de amostra

  • Urina
  • Sangue
  • Saliva
  • Outros

Com base no tipo de amostra, o mercado norte-americano de kits de teste caseiros está segmentado em urina, sangue, saliva, entre outros.

Uso

  • Descartável
  • Reutilizável

Com base na utilização, o mercado norte-americano de kits de teste caseiros está segmentado em descartáveis ​​e reutilizáveis.

Canais de distribuição

  • Farmácias de Retalho
  • Drogaria
  • Supermercado/Hipermercado
  • Farmácias on-line

Mercado de kits de teste doméstico

Com base nos canais de distribuição, o mercado norte-americano de kits de teste caseiros está segmentado em farmácias de retalho, drogarias, supermercados/hipermercados e farmácias online.

Análise/perspetivas regionais do mercado de kits de teste doméstico da América do Norte

O mercado norte-americano de kits de teste caseiros é analisado e são fornecidos insights e tendências do tamanho do mercado com base no tipo de teste, tipo, idade, tipo de amostra, utilização e canais de distribuição.

As regiões abrangidas no relatório de mercado de kits de teste caseiros da América do Norte são os EUA, o Canadá e o México.

Os EUA dominam o mercado norte-americano de kits de teste caseiros em termos de quota de mercado e receitas de mercado e continuarão a florescer o seu domínio durante o período de previsão. Isto deve-se aos elevados gastos com a saúde do país e à crescente consciencialização sobre o mercado de kits de testes caseiros na América do Norte.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas, análise das cinco forças de Porter e estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e as rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.

Cenário competitivo e análise da quota de mercado de kits de teste domésticos na América do Norte

O panorama competitivo do mercado norte-americano de kits de teste caseiros fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença na América do Norte, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento do produto, pipeline de ensaios clínicos, análise de marca, aprovações do produto, patentes, largura e amplitude do produto, domínio de aplicação, curva de segurança da tecnologia. Os dados fornecidos acima estão apenas relacionados com o foco das empresas relacionado com o mercado de kits de teste domésticos na América do Norte.

Alguns dos principais players que operam no mercado norte-americano de kits de teste caseiros são a Abbott, ACON Laboratories, Inc., Rapikit, BD, Cardinal Health, B. Braun Melsungen AG, Piramal Enterprises Ltd., Siemens Healthcare GmbH, Quidel Corporation , Bionime Corporation, SA Scientific, ARKRAY USA, Inc., Nova Biomedical, AdvaCare Pharma, AccuBioTech Co., Ltd., Atlas Medical UK, TaiDoc Technology Corporation, Drägerwerk AG & Co., PTE. Ltd, Atomo Diagnostics, RUNBIO BIOTECH CO., LTD., Mylan NV (uma subsidiária da Viatris, Inc.), MP BIOMEDICALS, VedaLab, Shanghai Chemtron Biotech Co.Ltd.


SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA AT-HOME TESTING KITS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE

2.8 MARKET POSITION COVERAGE GRID

2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.1 DBMR MARKET POSITION GRID

2.11 DISTRIBUTOR CHANNEL ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES

5 NORTH AMERICA AT- HOME TESTING KITS MARKET: REGULATIONS

5.1 REGULATION IN U.S

5.2 GUIDELINES FOR SELF-TESTING KITS

5.3 REGULATION IN EUROPE

5.4 GUIDELINES FOR TESTING KITS

5.5 REGULATION IN INDONESIA:

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 GROWING ADOPTION OF SELF-TESTING KITS

6.1.2 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES

6.1.3 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF HIV DIAGNOSIS

6.1.4 EASE OF USE AND LOW COSTS OF RAPID SELF-TEST KITS

6.2 RESTRAINTS

6.2.1 INACCURACY OF RESULTS BY SELF-TESTING KITS

6.2.2 STRINGENT GOVERNMENT REGULATIONS FOR MANUFACTURING AND DISTRIBUTION OF TESTING KITS

6.3 OPPORTUNITIES

6.3.1 ADVENT OF ADVANCED TECHNOLOGIES

6.3.2 EMERGING NEED FOR RAPID TESTING KITS FOR COVID-19 PANDEMIC

6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS

6.4 CHALLENGES

6.4.1 HIGH COMPETITION IN THE MEDICAL TECHNOLOGY INDUSTRY

6.4.2 REDUCTION IN RESEARCH & DEVELOPMENT BUDGETS

7 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE

7.1 OVERVIEW

7.2 GLUCOSE TESTS

7.3 INFECTIOUS DISEASES

7.4 PREGNANCY TEST

7.5 DRUG ABUSE TEST KITS

7.6 HIV TEST KIT

7.7 OVULATION PREDICTOR TEST KIT

7.8 OTHERS TEST TYPES

8 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TYPE

8.1 OVERVIEW

8.2 CASSETTES

8.2.1 RETAIL PHARMACIES

8.2.2 ONLINE PHARMACIES

8.2.3 DRUG STORE

8.2.4 SUPERMARKET/HYPERMARKET

8.3 STRIP

8.3.1 RETAIL PHARMACIES

8.3.2 ONLINE PHARMACIES

8.3.3 DRUG STORE

8.3.4 SUPERMARKET/HYPERMARKET

8.4 MIDSTREAM

8.4.1 RETAIL PHARMACIES

8.4.2 ONLINE PHARMACIES

8.4.3 DRUG STORE

8.4.4 SUPERMARKET/HYPERMARKET

8.5 DIP CARD

8.5.1 RETAIL PHARMACIES

8.5.2 ONLINE PHARMACIES

8.5.3 DRUG STORE

8.5.4 SUPERMARKET/HYPERMARKET

8.6 TEST PANEL

8.6.1 RETAIL PHARMACIES

8.6.2 ONLINE PHARMACIES

8.6.3 DRUG STORE

8.6.4 SUPERMARKET/HYPERMARKET

8.7 OTHERS

9 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY AGE

9.1 OVERVIEW

9.2 ADULT

9.3 GERIATRIC

9.4 PEDIATRIC

10 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE

10.1 OVERVIEW

10.2 BLOOD

10.3 URINE

10.4 SALIVA

10.5 OTHER SAMPLE TYPES

11 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY USAGE

11.1 OVERVIEW

11.2 DISPOSABLE

11.3 REUSABLE

12 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS

12.1 OVERVIEW

12.2 RETAIL PHARMACIES

12.3 ONLINE PHARMACIES

12.4 DRUG STORE

12.5 SUPERMARKET/HYPERMARKET

13 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY REGION

13.1 NORTH AMERICA

13.1.1 U.S.

13.1.2 CANADA

13.1.3 MEXICO

14 NORTH AMERICA AT-HOME TESTING KITS MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 ABBOTT

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUS ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENT

16.2 SIEMENS HEALTHCARE GMBH

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUS ANALYSIS

16.2.3 PRODUCT PORTFOLIO

16.2.4 RECENT DEVELOPMENTS

16.3 F. HOFFMANN- LA ROCHE LTD

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 BD

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 PRODUCT PORTFOLIO

16.4.4 RECENT DEVELOPMENTS

16.5 DRÄGERWERK AG & CO. KGAA

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENTS

16.6 LIFESCAN IP HOLDINGS, LLC

16.6.1 COMPANY SNAPSHOT

16.6.2 COMPANY SHARE ANALYSIS

16.6.3 PRODUCT PORTFOLIO

16.6.4 RECENT DEVELOPMENTS

16.7 ASCENSIA DIABETES CARE HOLDINGS AG.

16.7.1 COMPANY SNAPSHOT

16.7.2 COMPANY SHARE ANALYSIS

16.7.3 PRODUCT PORTFOLIO

16.7.4 RECENT DEVELOPMENTS

16.8 NECTAR LIFESCIENCES LTD. (RAPIKIT)

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENTS

16.9 ACON LABORATORIES, INC.

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENTS

16.1 QUIDEL CORPORATION.

16.10.1 COMPANY SNAPSHOT

16.10.2 REVENUE ANALYSIS

16.10.3 PRODUCT PORTFOLIO

16.10.4 RECENT DEVELOPMENTS

16.11 ARKRAY USA, INC.

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENTS

16.12 BTNX INC.

16.12.1 COMPANY SNAPSHOT

16.12.2 PRODUCT PORTFOLIO

16.12.3 RECENT DEVELOPMENTS

16.13 ATOMO DIAGNOSTICS

16.13.1 COMPANY SNAPSHOT

16.13.2 REVENUE ANALYSIS

16.13.3 PRODUCT PORTFOLIO

16.13.4 RECENT DEVELOPMENTS

16.14 EUROFINS SCIENTIFIC

16.14.1 COMPANY SNAPSHOT

16.14.2 REVENUE ANALYSIS

16.14.3 PRODUCT PORTFOLIO

16.14.4 RECENT DEVELOPMENTS

16.15 PIRAMAL ENTERPRISES LTD.

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCT PORTFOLIO

16.15.4 RECENT DEVELOPMENTS

16.16 BIONIME CORPORATION

16.16.1 COMPANY SNAPSHOT

16.16.2 REVENUE ANALYSIS

16.16.3 PRODUCT PORTFOLIO

16.16.4 RECENT DEVELOPMENTS

16.17 NOVA BIOMEDICAL

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 CARDINAL HEALTH.

16.18.1 COMPANY SNAPSHOT

16.18.2 REVENUE ANALYSIS

16.18.3 PRODUCT PORTFOLIO

16.18.4 RECENT DEVELOPMENTS

16.19 ORASURE TECHNOLOGIES

16.19.1 COMPANY SNAPSHOT

16.19.2 REVENUE ANALYSIS

16.19.3 PRODUCT PORTFOLIO

16.19.4 RECENT DEVELOPMENTS

16.2 BIOLYTICAL LABORATORIES INC.

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENTS

16.21 EVERLYWELL, INC.

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENTS

16.22 SA SCIENTIFIC LTD.

16.22.1 COMPANY SNAPSHOT

16.22.2 PRODUCT PORTFOLIO

16.22.3 RECENT DEVELOPMENTS

16.23 CLEARBLUE (A SUBSIDIARY OF SWISS PRECISION DIAGNOSTICS GMBH)

16.23.1 COMPANY SNAPSHOT

16.23.2 PRODUCT PORTFOLIO

16.23.3 RECENT DEVELOPMENTS

16.24 BIOSYNEX

16.24.1 COMPANY SNAPSHOT

16.24.2 PRODUCT PORTFOLIO

16.24.3 RECENT DEVELOPMENTS

16.25 PRIMA LAB SA

16.25.1 COMPANY SNAPSHOT

16.25.2 PRODUCT PORTFOLIO

16.25.3 RECENT DEVELOPMENTS

16.26 MP BIOMEDICALS.

16.26.1 COMPANY SNAPSHOT

16.26.2 PRODUCT PORTFOLIO

16.26.3 RECENT DEVELOPMENTS

16.27 STERILAB SERVICES

16.27.1 COMPANY SNAPSHOT

16.27.2 PRODUCT PORTFOLIO

16.27.3 RECENT DEVELOPMENTS

16.28 CHEMBIO DIAGNOSTICS, INC.

16.28.1 COMPANY SNAPSHOT

16.28.2 REVENUE ANALYSIS

16.28.3 PRODUCT PORTFOLIO

16.28.4 RECENT DEVELOPMENTS

16.29 BIOSURE

16.29.1 COMPANY SNAPSHOT

16.29.2 PRODUCT PORTFOLIO

16.29.3 RECENT DEVELOPMENTS

16.3 SELFDIAGNOSTICS OU

16.30.1 COMPANY SNAPSHOT

16.30.2 PRODUCT PORTFOLIO

16.30.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

Lista de Tabela

TABLE 1 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 2 NORTH AMERICA GLUCOSE TESTS IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 NORTH AMERICA INFECTIOUS DISEASES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 NORTH AMERICA PREGNANCY TEST IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 5 NORTH AMERICA DRUG ABUSE TEST KITS IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 NORTH AMERICA HIV TEST KIT IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 NORTH AMERICA OVULATION PREDICTOR TEST KIT IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 NORTH AMERICA OTHERS TEST TYPES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 10 NORTH AMERICA CASSETTES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 NORTH AMERICA CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 12 NORTH AMERICA STRIP IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 NORTH AMERICA STRIP IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 14 NORTH AMERICA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 NORTH AMERICA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 16 NORTH AMERICA DIP CARD IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 NORTH AMERICA DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 18 NORTH AMERICA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 NORTH AMERICA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 20 NORTH AMERICA OTHERS IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)

TABLE 22 NORTH AMERICA ADULT IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 NORTH AMERICA GERIATRIC IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 NORTH AMERICA PEDIATRIC IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)

TABLE 26 NORTH AMERICA BLOOD IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 NORTH AMERICA URINE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 NORTH AMERICA SALIVA IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 NORTH AMERICA OTHER SAMPLE TYPES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)

TABLE 31 NORTH AMERICA DISPOSABLE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 NORTH AMERICA REUSABLE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 34 NORTH AMERICA RETAIL PHARMACIES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 NORTH AMERICA ONLINE PHARMACIES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 NORTH AMERICA DRUG STORE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 NORTH AMERICA SUPERMARKET/HYPERMARKET IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 39 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 40 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 41 NORTH AMERICA STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 42 NORTH AMERICA CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 43 NORTH AMERICA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 44 NORTH AMERICA DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 45 NORTH AMERICA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 46 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)

TABLE 47 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)

TABLE 48 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)

TABLE 49 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 50 U.S. AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 51 U.S. AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 52 U.S. STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 53 U.S. CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 54 U.S. MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 55 U.S. DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 56 U.S. TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 57 U.S. AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)

TABLE 58 U.S. AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)

TABLE 59 U.S. AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)

TABLE 60 U.S. AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 61 CANADA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 62 CANADA AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 63 CANADA STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 64 CANADA CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 65 CANADA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 66 CANADA DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 67 CANADA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 68 CANADA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)

TABLE 69 CANADA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)

TABLE 70 CANADA AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)

TABLE 71 CANADA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 72 MEXICO AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 73 MEXICO AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 74 MEXICO STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 75 MEXICO CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 76 MEXICO MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 77 MEXICO DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 78 MEXICO TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

TABLE 79 MEXICO AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)

TABLE 80 MEXICO AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)

TABLE 81 MEXICO AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)

TABLE 82 MEXICO AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)

Lista de Figura

FIGURE 1 NORTH AMERICA AT-HOME TESTING KITS MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA AT-HOME TESTING KITS MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA AT-HOME TESTING KITS MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA AT-HOME TESTING KITS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA AT-HOME TESTING KITS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA AT-HOME TESTING KITS MARKET: MARKET POSITION COVERAGE GRID

FIGURE 7 NORTH AMERICA AT-HOME TESTING KITS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA AT-HOME TESTING KITS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA AT-HOME TESTING KITS MARKET: DISTRIBUTOR CHANNEL ANALYSIS

FIGURE 10 NORTH AMERICA AT-HOME TESTING KITS MARKET: SEGMENTATION

FIGURE 11 GROWING ADOPTION OF SELF-TESTING KITS IS EXPECTED TO DRIVE NORTH AMERICA AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 GLUCOSE TEST IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE IN 2022 & 2029

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE AND ASIA-PACIFIC IS THE FASTEST GROWING REGION IN THE NORTH AMERICA AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA AT-HOME TESTING KITS MARKET

FIGURE 15 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2021

FIGURE 16 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2022-2029 (USD MILLION)

FIGURE 17 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, CAGR (2022-2029)

FIGURE 18 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, LIFELINE CURVE

FIGURE 19 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, 2021

FIGURE 20 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 21 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 22 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 23 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY AGE, 2021

FIGURE 24 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY AGE, 2022-2029 (USD MILLION)

FIGURE 25 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY AGE, CAGR (2022-2029)

FIGURE 26 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY AGE, LIFELINE CURVE

FIGURE 27 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2021

FIGURE 28 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2022-2029 (EURO MILLION)

FIGURE 29 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, CAGR (2022-2029)

FIGURE 30 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, LIFELINE CURVE

FIGURE 31 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, 2021

FIGURE 32 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, 2022-2029 (EURO MILLION)

FIGURE 33 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, CAGR (2022-2029)

FIGURE 34 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, LIFELINE CURVE

FIGURE 35 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 36 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 37 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 38 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 39 NORTH AMERICA AT-HOME TESTING KITS MARKET: SNAPSHOT (2021)

FIGURE 40 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2021)

FIGURE 41 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 42 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 43 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE (2022-2029)

FIGURE 44 NORTH AMERICA AT-HOME TESTING KITS MARKET: COMPANY SHARE 2021 (%)

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

North America At-Home Testing Kits Market will grow at a CAGR of 6.3% by 2029.
The significant factors flourishing the growth of the North America At-Home Testing Kits Market are Growing adoption of self-testing kits , and Easy availability of self-testing kits at pharmacies.
The major players operating in the North America At-Home Testing Kits Market are Abbott, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, BD, Drägerwerk AG & Co. KGaA, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG., Nectar Lifesciences Ltd. (Rapikit), ACON Laboratories, Inc., Quidel Corporation., ARKRAY USA, Inc., BTNX INC., Atomo Diagnostics, Eurofins Scientific, Piramal Enterprises Ltd., Bionime Corporation., Nova Biomedical, Cardinal Health., OraSure Technologies, Biolytical Laboratories Inc., Everlywell, Inc., SA Scientific Ltd., Clearblue (a subsidiary of Swiss Precision Diagnostics GmbH), Biosynex, PRIMA Lab SA, MP BIOMEDICALS., Sterilab Services, Chembio Diagnostics, Inc., BioSure, Selfdiagnostics OU among others.
The major countries covered in the North America At-Home Testing Kits Market are U.S., Canada and Mexico.